Alcon & STAAR leap on CMS ruling

Article

The Centers for Medicare and Medicaid Services (CMS) has issued a ruling that will allow Medicare beneficiaries undergoing cataract surgery to choose an astigmatism-correcting intraocular lens (IOL).

The Centers for Medicare and Medicaid Services (CMS) has issued a ruling that will allow Medicare beneficiaries undergoing cataract surgery to choose an astigmatism-correcting intraocular lens (IOL).

Similar to the CMS decision allowing cataract patients access to presbyopia-correcting IOLs, this new ruling will allow patients to pay the additional charges for the correction of pre-existing astigmatism while Medicare will provide customary reimbursement for the cataract surgery.

Both Alcon and STAAR Surgical believe that their Toric lenses (AcrySof Toric IOL, Alcon; STAAR Toric IOL, STAAR) will be included under this ruling. Such lenses allow a surgeon to replace the cataract lens and provide refractive correction for the astigmatic cornea in a single procedure.

Related Videos
Josefina Botta, MD, MSc, at ASCRS 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
© 2024 MJH Life Sciences

All rights reserved.